Cyt-108

N/A

Report date: 2024/03/28 15:56:25

Base Information

Drug NameCyt-108

Drug Alias NameRecombinant A2Mα-2 macroglobulinAlpha-2-MacroglobulinCyt-108α2M +[6]

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionPeptide hydrolase inhibitors

TargetsPeptide hydrolase

Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCytonics Co

China Registration ClassN/A

Active CompaniesCytonics Co

Inactive CompaniesN/A

Active IndicationsOsteoarthritis, KneeOsteoarthritis

Inactive IndicationsN/A

ATC CodeN/A